Review Outlines Issues Relating to Obtaining Surgical Consent
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 7, 2023 -- There is currently low-level evidence about surgical consent processes that can inform clinical practice, and surgical consent is frequently obtained by junior doctors in a suboptimal process, according to a review published online June 25 in the Journal of Clinical Nursing.
Therese M. Gardiner, M.N., from Griffith University in Southport, Australia, and colleagues provided an overview of the literature about the process of obtaining informed consent from adults undergoing planned surgery. The scoping review included 53 articles: 39 primary and 14 secondary research publications.
The researchers identified three key findings: currently, there is low-level evidence relating to the surgical consent processes to inform clinical practice; junior doctors often obtain surgical consent, but this process is likely suboptimal; and current knowledge gaps include capacity assessment, decision-making, and preprocedural consent checks.
"While the responsibility for obtaining surgical consent lies with the surgeon, the nurse's role is crucial as they act as a safety net," the authors write. "This holds particular importance given the frequency of junior doctors consenting patients for surgery, coupled with incomplete procedural information delivered."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.